Mitral valve thromboendocarditis in a patient with a novel coronavirus disease COVID-19

Authors: Yarmedova S.F., Piksina G.F., Borisova E.V., Kalyuzhnaya A.S.

Company: City clinical hospital named after E.O. Mukhin, Moscow, Russian Federation

For correspondence:  Sign in or register.

Type:  Clinical Cases


For citation: Yarmedova S.F., Piksina G.F., Borisova E.V., Kalyuzhnaya A.S. Mitral valve thromboendocarditis in a patient with a novel coronavirus disease COVID-19. Creative Cardiology. 2022; 16 (2): 250–7 (in Russ.). DOI: 10.24022/1997-3187-2022-16-2-250-257

Received / Accepted:  28.04.2022 / 07.06.2022

Keywords: novel coronavirus infectious disease thromboendocarditis infective endocarditis COVID-19

Subscribe 🔒



Since the beginning of the novel coronavirus disease pandemic, which has claimed millions of lives around the world, vaccines and effective therapeutic strategies have been developed, but along with this, approaches to the diagnosis and treatment of well-known diseases have changed, these metamorphoses also affected cardiovascular diseases. So, a flurry of publications is devoted to the development of myocarditis and myocardial damage within the framework of novel coronavirus infectious disease, however, there are practically no data on the concomitant course of COVID-19 and infective endocarditis or thromboendocarditis. In our case, we demonstrate the combined course of novel coronavirus infectious disease, viral pneumonia and infectious thromboendocarditis in a patient with pre-existing corrected valvular heart disease. Of particular interest are the pathogenetic links, the nature of the clinical course and prognosis in the combination of these nosologies.


  1. Fisun A.Y., Cherkashin D.V., Tyrenko V.V., Zhdanov C.V., Kozlov C.V. Role of renin-angiotensinaldosterone system in the interaction with coronavirus SARS-CoV-2 and in the development of strategies for prevention and treatment of new coronavirus infection (COVID-19). Arterial’naya Gipertenziya (Arterial Hypertension). 2020; 26 (3): 248–62 (in Russ.). DOI: 10.18705/1607-419X2020-26-3-248-262
  2. Kovtyukh I.V., Gendlin G.E., Nikitin I.G., Baymukanov A.M., Nikitin A.E., Dvornikova S.N. The value of indicators characterizing the state of the cardiovascular system in assessing the hospital prognosis of COVID-19 patients. Kardiologiia. 2021; 61 (10): 26–35 (in Russ.). DOI: 10.18087/cardio.2021.10.n1553
  3. Kogan E.A., Kukleva A.D., Berezovsky Yu.S, Blagova O.V., Zharkov N.V., Ainetdinova D.Kh., Demyashkin G.A. Clinical and morphological characteristics of SARS-CoV-2-related myocarditis proven by the presence of viral RNA and proteins in myocardial tissue. Archive of Pathology (Arkhiv Patologii). 2021; 83 (4): 5–13 (in Russ.). DOI: 10.17116/patol2021830415
  4. Poteshkina N.G., Lysenko M.A., Kovalevskaya E.A., Fomina D.S., Samsonova I.V., Parshin V.V. et al. Cardiac damage in patients with COVID-19 coronavirus infection. Arterial’naya Gipertenziya (Arterial Hypertension). 2020; 26 (3): 277–87 (in Russ.). DOI: 10.18705/1607-419X2020-26-3-277-287
  5. Blagova O.V., Ainetdinova D.Kh., Kogan E.A., Lutokhina V.M., Novosadov V.M., Savina P.O. et al. Infectious and non-bacterial thromboendocarditis in patients with post-covid viral-immune myocarditis. Russian Journal of Cardiology. 2022; 27 (4): 118–30 (in Russ.). DOI: 10.15829/1560-4071-2022-4827
  6. Choudhury I., Han H., Manthani K., Gandhi S., Dabhi R. COVID-19 as a possible cause of functional exhaustion of CD4 and CD8 T-cells and persistent cause of methicillin-sensitive staphylococcus aureus bacteremia. Cureus. 2020; 12 (7): e9000. DOI: 10.7759/cureus.9000
  7. Lebedeva A.A., Kulikov A.N., Kovalchuk I.P., Kadinskaya M.I., Ginzburg A.M., Vlasov T.D. Endothelial dysfunction and thrombotic events in patients with severe novel coronavirus infection COVID-19. The Scientific Notes of the Pavlov University. 2021; 28 (4): 38–47 (in Russ.). DOI: 10.24884/1607-4181-2021-28-4-38-47

About Authors

  • Sevindzh F. Yarmedova, Cardiologist; ORCID
  • Galina F. Piksina, Cand. Med. Sci., Head of Department, Cardiologist; ORCID
  • Ekaterina V. Borisova, Cand. Med. Sci., Cardiologist; ORCID
  • Anna S. Kalyuzhnaya, Cand. Med. Sci., Physician; ORCID

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery